IFNG and myeloid sarcoma: Compared with healthy individuals, Th17 cells from MS patients have higher levels of EP2 receptor, resulting in increased expression of proinflammatory cytokines like IFN-γ and GM-CSF and pathogenicity of Th17 cells (Kofler et al., 2014).